SUMOylation inhibition enhances dexamethasone sensitivity in multiple myeloma
Li Du(City Of Hope National Medical Center), Steven T. Rosen(City of Hope)
Cited by 55
Related Papers
Role of SUMO activating enzyme in cancer stem cell maintenance and self-renewal
|Nature Communications|2016|132
Enzastaurin (LY317615), a protein kinase Cβ inhibitor, inhibits the AKT pathway and induces apoptosis in multiple myeloma cell lines
|Molecular Cancer Therapeutics|2006|81
Targeting the metabolic vulnerability of acute myeloid leukemia blasts with a combination of venetoclax and 8-chloro-adenosine
|Journal of Hematology & Oncology|2021|66
Targeting Glucose Consumption and Autophagy in Myeloma with the Novel Nucleoside Analogue 8-Aminoadenosine
|Journal of Biological Chemistry|2009|44
SUMOylation inhibition enhances multiple myeloma sensitivity to lenalidomide
|Cancer Gene Therapy|2022|20